|
It was reported that a patient underwent a cabg heart procedure on (b)(6) 2020 and suture was used.During the procedure, while suturing the distal portion of the anastomosis, the suture broke at the mid-point.Another like device was used to complete the procedure with no adverse patient consequences reported.No additional information was provided.
|
|
(b)(4).Date sent to the fda: 04/07/2020.Additional information: d4, d10, h4, h6.A manufacturing record evaluation was performed for the finished device lot lph748, and no non-conformances were identified.Additional h3 investigation summary: it was received for analysis five unopened samples of product code epm8745, lot lph748.During the visual inspection of five unopened samples, no defects were found on the packages.The swage and attachment area were noted to be as expected.The sutures were dispensed without problems and examined along of the strand and no defects, damaged or suture breakage were noted.A functional test was performed and the tensile strength force was above the minimum requirement.The manufacturing records were reviewed, and the manufacturing/packaging criteria were met prior to the release of this batch.Per the condition of the samples received, no performance - breakage suture was found and the tested samples met the finished goods requirements.
|